HC Stocks Review! Express Scripts Holding Company (ESRX), UnitedHealth Group Inc (UNH)
Shares of Express Scripts Holding Company (NASDAQ:ESRX) ended Monday session in green amid volatile trading. The shares closed up +0.51 points or 0.73% at $70.57 with 1.63 million shares getting traded. Post opening the session at $70.44, the shares hit an intraday low of $70.38 and an intraday high of $70.90 and the price vacillated in this range throughout the day. The company has a market cap of $44.15 billion and the numbers of outstanding shares have been calculated to be 630.22 million shares.
Express Scripts Holding Company (ESRX) announced its intention to release its third quarter earnings on Tuesday, October 25, 2016 after the market closes and will hold its quarterly conference call to discuss third quarter results on Wednesday, October 26, 2016, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).
The call is being broadcast and can be accessed at the Investor Information section of Express Scripts’ web site at www.express-scripts.com/corporate. RealPlayer or Windows Media Player is needed to listen to the broadcast and free downloads of these players are available at the broadcast site.
A slide presentation will also be posted on Express Scripts’ website. Following the conference call, both the slide presentation and the webcast will remain available on the Investor Information section of Express Scripts’ website for 90 days.
Shares of UnitedHealth Group Inc (NYSE:UNH) ended Monday session in green amid volatile trading. The shares closed up +1.42 points or 1.04% at $138.08 with 2.59 million shares getting traded. Post opening the session at $136.97, the shares hit an intraday low of $136.97 and an intraday high of $138.35 and the price vacillated in this range throughout the day. The company has a market cap of $131.69 billion and the numbers of outstanding shares have been calculated to be 952.39 million shares.
UnitedHealth Group Inc (UNH) introduced its 2017 Medicare Advantage and Part D prescription drug plans, building on its market-leading 2016 medical plan growth by featuring continued stability in its Medicare Advantage plans’ premiums and benefits as well as a new low-premium prescription drug plan introduced in collaboration with Walgreens.
The new AARP® MedicareRx Walgreens (PDP) plan, insured through UnitedHealthcare, is designed to appeal to consumers who are looking for the peace of mind that Part D prescription drug coverage offers and appreciate the convenience of shopping at their neighborhood Walgreens or Duane Reade, the plan’s preferred retail pharmacy chains that are included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (WBA).
With its low $22.50 premium as well as $0 co-pays for tier 1 medications and $0 deductible for tier 1 and 2 medications purchased at Walgreens and Duane Reade pharmacies, the plan is an ideal choice for cost-conscious consumers looking to maximize the affordability of their Part D coverage. The $22.50 premium makes it one of the lowest-cost Part D plans available nationwide in 2017.